The authors examine the origin, benefits, and challenges of pragmatic clinical trials to assess the ultimate value of this research design.
Eric B. Larson, MD, MPH
Advertisement
Articles by Eric B. Larson, MD, MPH
A systematic review of the literature reporting the cost of dementia among Medicare managed care plans found a limited and dated body of evidence.
A 12-month evaluation of a patient-centered medical home demonstration indicated improvement in quality of care without an increase in overall costs.
Advertisement
Latest Updated Articles
- A Value Proposition for Pragmatic Clinical Trials
September 8th 2022
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor
4
Clinicians Confront Fragmented Care and the Silent Burden of Undertreated Atopic Dermatitis
5